Everolimus in the treatment of neuroendocrine tumors: efficacy, side-effects, resistance, and factors affecting its place in the treatment sequence
Contact us today at (816) 214-5260 or email [email protected] to schedule a consultation and explore how GLP-1 medications and peptides can be integrated into your personalized weight loss plan
2022 JAMA Internal Medicine meta-analysis: pooling 76 randomised controlled trials, GLP-1 receptor agonist use was associated with a relative risk of 1.37 for biliary disease compared with placebo or other treatments
Do not let total calories drop below your daily floor (1,200 for women, 1,500 for men)
Malnutrition Stemming from Poor Nutrient Absorption
Building the lifestyle foundation during treatment The single most important thing you can do during GLP-1 treatment is prepare for life after it